 I. Evaluating blocks of tissue from pre-treatment diagnostic biopsies and tissue from biopsies taken during therapy, when available from enrolled patients, for expression of markers beclin1, light chain 3 LC3, sequestosome 1 p62 and hypoxia up-regulated 1 GRp170 as indicators of autophagy potential. 